Why the study?
Does nonanticoagulant heparin (ODSH) reduce myocardial reperfusion injury and myocyte Na+ and Ca2+ loading in animal models of ischemia-reperfusion?
Does nonanticoagulant heparin (ODSH) reduce myocardial reperfusion injury and myocyte Na+ and Ca2+ loading in animal models of ischemia-reperfusion?
Nonanticoagulant heparin (ODSH) reduces myocardial reperfusion injury by decreasing Na+ and Ca2+ loading during early reperfusion, suggesting a novel ion channel-mediated mechanism of protection.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for ODSH in myocardial reperfusion injury; prospective human trials needed before clinical adoption.
Barry et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: